ondansetron has been researched along with Death, Sudden, Cardiac in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzuillo, P | 1 |
| Benettoni, A | 1 |
| Germani, C | 1 |
| Ferrara, G | 1 |
| D'Agata, B | 1 |
| Barbi, E | 1 |
1 review available for ondansetron and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Acquired long QT syndrome: a focus for the general pediatrician.
Topics: Adolescent; Death, Sudden, Cardiac; Electrocardiography; Female; General Practitioners; Humans; Long | 2014 |